Amedeo Smart

Free Medical Literature Service

 

Amedeo

Schizophrenia
  Free Subscription

Articles published in
Acta Psychiatr Scand
    March 2026
  1. TSAI SY, Lee YT, Sajatovic M, Hung S, et al
    Association Between Accelerated Atherosclerosis and High-Sensitivity C-Reactive Protein Levels in Bipolar Disorder and Schizophrenia.
    Acta Psychiatr Scand. 2026 Mar 5. doi: 10.1111/acps.70083.
    >> Share

    February 2026
  2. BIOQUE M, Perez-Ramos A, Llorca-Bofi V, Penades R, et al
    Clinical Implications of Autistic Features in Patients With a First Episode of Psychosis.
    Acta Psychiatr Scand. 2026 Feb 25. doi: 10.1111/acps.70079.
    >> Share

    January 2026
  3. BRAILLON A
    Mortality Gap for People With Schizophrenia Spectrum Disorders: An Elephant in the Room?
    Acta Psychiatr Scand. 2026 Jan 19. doi: 10.1111/acps.70070.
    >> Share

  4. FUJIWARA M, Yamada Y, Ishii T, Watanabe T, et al
    Impact of Schizophrenia Spectrum Disorders on the Receipt of Invasive and Systemic Therapy for Colorectal Cancer: A Nationwide Multicenter Retrospective Cohort Study in Japan.
    Acta Psychiatr Scand. 2026 Jan 14. doi: 10.1111/acps.70065.
    >> Share

  5. CLOUGHER D, De Prisco M, Sole B, Montejo L, et al
    Resilience in Bipolar Disorder Compared to Clinical and Non-Clinical Populations: A Systematic Review and Meta-Analysis.
    Acta Psychiatr Scand. 2026;153:6-23.
    >> Share

    December 2025
  6. WANG CM, Mudiyanselage SPK, Wang PC, Hsu CF, et al
    Digital Social Cognition Training Enhancing Social Cognition in Patients With Schizophrenia: A Systematic Review and Meta-Analysis.
    Acta Psychiatr Scand. 2025 Dec 28. doi: 10.1111/acps.70060.
    >> Share

  7. CULLEN AE
    Evidence of a Widening Mortality Gap for People With Schizophrenia Spectrum Disorders: Implications for Early Intervention Services.
    Acta Psychiatr Scand. 2025 Dec 19. doi: 10.1111/acps.70061.
    >> Share

  8. FUGLSANG NFB, Madsen NM, Jacobsen SL, Frokjaer JE, et al
    Efficacy and Acceptability of Licensed and Off-Label Pharmacological Interventions for Insomnia in Patients With Severe Mental Illness: A Systematic Review and Meta-Analysis of Randomised Trials.
    Acta Psychiatr Scand. 2025;152:405-421.
    >> Share

    November 2025

  9. Correction to "Homocysteine Levels and Glucose Metabolism in Non-Obese, Non-Diabetic Chronic Schizophrenia".
    Acta Psychiatr Scand. 2025 Nov 5. doi: 10.1111/acps.70045.
    >> Share


  10. Correction to "A Double-Blind, Placebo-Controlled Trial of Rosiglitazone for Clozapine-Induced Glucose Metabolism Impairment in Patients with Schizophrenia".
    Acta Psychiatr Scand. 2025 Nov 3. doi: 10.1111/acps.70044.
    >> Share

    October 2025
  11. HUANG MH, Cheng CM, Hsu JW, Bai YM, et al
    Risk of Stroke in Patients With Schizophrenia, Bipolar Disorder, and Major Depressive Disorder: A Cohort Study of 183,504 Subjects.
    Acta Psychiatr Scand. 2025 Oct 30. doi: 10.1111/acps.70043.
    >> Share

  12. ERCIS M, Miola A, Ortiz-Orendain J, Pazdernik VK, et al
    Three Distinct Pathways to First Episode Mania and Psychosis: Latent Class Analysis of Antecedent Psychopathology.
    Acta Psychiatr Scand. 2025;152:278-289.
    >> Share

    September 2025
  13. HIERONYMUS F, Hieronymus M, Sjostedt A, Nilsson S, et al
    Predicting Remission in Schizophrenia Using Machine Learning-Assessing the Impact of Sample Size and Predictor Overinclusion.
    Acta Psychiatr Scand. 2025 Sep 10. doi: 10.1111/acps.70037.
    >> Share

  14. PEYROVIAN B, Palaniyappan L, Kolivakis TT, Margolese HC, et al
    Pharmacological and Mechanistic Interventions for Cognitive Impairment Associated With Schizophrenia: A Review of Registered Clinical Trials.
    Acta Psychiatr Scand. 2025 Sep 4. doi: 10.1111/acps.70034.
    >> Share

  15. NORMARK S, Wium-Andersen MK, Osler M, Wium-Andersen IK, et al
    Risk of Dementia in Patients Suffering From Psychosis-A Danish Register-Based Cohort Study.
    Acta Psychiatr Scand. 2025;152:180-186.
    >> Share

  16. TAYLOR D, Gee S, Helthuis M, Oloyede E, et al
    The Safety of 12-Weekly Monitoring of Neutrophil Count in Long-Term Clozapine Patients.
    Acta Psychiatr Scand. 2025;152:187-192.
    >> Share

    August 2025
  17. VAURIO O, Tiihonen J, Lahteenvuo M, Lieslehto J, et al
    Psychopathic Traits Associate With Later Schizophrenia.
    Acta Psychiatr Scand. 2025 Aug 25. doi: 10.1111/acps.70027.
    >> Share

    July 2025
  18. XIE Y, Li C, Guan M, Zhang T, et al
    Transcriptomic and Neurotransmitter Insights Into Gray Matter Volume Changes From 1 Hz rTMS in Treating Schizophrenia With Auditory Verbal Hallucinations.
    Acta Psychiatr Scand. 2025 Jul 6. doi: 10.1111/acps.70014.
    >> Share

  19. GIBSON L, Mueller C, Stewart R
    Psychosis and Dementia-Disorders of Disadvantage.
    Acta Psychiatr Scand. 2025 Jul 6. doi: 10.1111/acps.70012.
    >> Share

  20. SMITH RL, Andreassen OA, Kane JM, Schoretsanitis G, et al
    Correlation Between Clozapine and CRP Levels in Relation to Smoking Status.
    Acta Psychiatr Scand. 2025;152:69-76.
    >> Share

    June 2025
  21. PER BL, Loeser S, Edwards S, Lee WS, et al
    The Impact of Metformin on Weight and Waist Circumference in Patients Treated With Clozapine: A One-Year Retrospective Cohort Study.
    Acta Psychiatr Scand. 2025;151:719-730.
    >> Share

    March 2025
  22. DE WINTER L, Jelsma A, Vermeulen JM, Vellinga A, et al
    Interrelationships of Changes in Outcome Domains in Patients With Schizophrenia Spectrum Disorders: A Meta-Analysis.
    Acta Psychiatr Scand. 2025 Mar 30. doi: 10.1111/acps.13808.
    >> Share

    December 2024
  23. FORTE MF, Clougher D, Segura AG, Mezquida G, et al
    From Genetics to Psychosocial Functioning: Unraveling the Mediating Roles of Cognitive Reserve, Cognition, and Negative Symptoms in First-Episode Psychosis.
    Acta Psychiatr Scand. 2024 Dec 25. doi: 10.1111/acps.13779.
    >> Share

    November 2024
  24. ODSBU I, Hamina A, Hjellvik V, Handal M, et al
    Initiation of Antipsychotics During the First Year After First-Episode Psychosis: A Population-Based Study.
    Acta Psychiatr Scand. 2024 Nov 29. doi: 10.1111/acps.13776.
    >> Share

  25. TAHMAZOV E, Bosse J, Glemain B, Nabbe P, et al
    Impact of Early Intervention for Early Psychosis on Suicidal Behavior-A Meta-Analysis.
    Acta Psychiatr Scand. 2024 Nov 27. doi: 10.1111/acps.13773.
    >> Share

  26. D'ANDREA G, Quattrone D, Tripoli G, Spinazzola E, et al
    Variation of subclinical psychosis as a function of population density across different European settings: Findings from the multi-national EU-GEI study.
    Acta Psychiatr Scand. 2024 Nov 1. doi: 10.1111/acps.13767.
    >> Share

    October 2024
  27. MADSEN NM, Sorensen MA, Danielsen AA, Hojlund M, et al
    The risk of diabetes and HbA1c deterioration during antipsychotic drug treatment: A Danish two-cohort study among patients with first-episode schizophrenia.
    Acta Psychiatr Scand. 2024 Oct 8. doi: 10.1111/acps.13760.
    >> Share

    September 2024
  28. VAN OPSTAL DPJ, Kia SM, Jakob L, Somers M, et al
    Psychosis Prognosis Predictor: A continuous and uncertainty-aware prediction of treatment outcome in first-episode psychosis.
    Acta Psychiatr Scand. 2024 Sep 18. doi: 10.1111/acps.13754.
    >> Share

  29. COHN AB, Yang YS
    The effects of individualism versus collectivism on clozapine policy stringency.
    Acta Psychiatr Scand. 2024;150:180-181.
    >> Share

    August 2024
  30. KEINANEN J, Eskelinen S, From T, Laurikainen H, et al
    Psychosis metabolic risk calculator (PsyMetRiC) in early psychosis: External validation study in Finland.
    Acta Psychiatr Scand. 2024 Aug 29. doi: 10.1111/acps.13752.
    >> Share

  31. LIN YP, Chen WY, Pan CH, Su SS, et al
    Age-stratified risk of suicide in patients with schizophrenia.
    Acta Psychiatr Scand. 2024 Aug 14. doi: 10.1111/acps.13747.
    >> Share

  32. AMBROSEN KS, Lemvigh CK, Nielsen MO, Glenthoj BY, et al
    Using computer vision of facial expressions to assess symptom domains and treatment response in antipsychotic-naive patients with first-episode psychosis.
    Acta Psychiatr Scand. 2024 Aug 12. doi: 10.1111/acps.13743.
    >> Share

    July 2024
  33. SASS MR, Christensen AMB, Christensen ML, Gruber E, et al
    Liraglutide 3.0 mg once daily for the treatment of overweight and obesity in patients hospitalised at a forensic psychiatric department: A 26-week open-label feasibility study.
    Acta Psychiatr Scand. 2024;150:35-47.
    >> Share

    June 2024
  34. BERKHOF M, van der Stouwe ECD, Pot-Kolder RMCA, van der Gaag M, et al
    Exploring the role of clinical and demographic characteristics on the effects of virtual reality cognitive behavioral therapy for psychosis: A moderator analysis.
    Acta Psychiatr Scand. 2024 Jun 9. doi: 10.1111/acps.13713.
    >> Share

    April 2024
  35. CLARK I, Wallman P, Gee S, Taylor D, et al
    Long term impact of 3-monthly paliperidone palmitate on hospitalisation in patients with schizophrenia: Six-year mirror image study.
    Acta Psychiatr Scand. 2024 Apr 15. doi: 10.1111/acps.13691.
    >> Share

  36. DALAL TC, Liang L, Silva AM, Mackinley M, et al
    Speech based natural language profile before, during and after the onset of psychosis: A cluster analysis.
    Acta Psychiatr Scand. 2024 Apr 10. doi: 10.1111/acps.13685.
    >> Share

    February 2024
  37. BERGQVIST J, Hedskog S, Hedman C, Schultz T, et al
    Patients with both cancer and psychosis-to what extent do they receive specialized palliative care.
    Acta Psychiatr Scand. 2024 Feb 18. doi: 10.1111/acps.13666.
    >> Share

  38. TSUKAHARA M, So R, Yoshimura Y, Nakajima S, et al
    Response to the letter to the Editor from Araujo and colleagues on the research article entitled, "Effect of smoking habits and concomitant valproic acid use on relapse in patients with treatment-resistant schizophrenia receiving clozapine: A 1-year r
    Acta Psychiatr Scand. 2024 Feb 15. doi: 10.1111/acps.13674.
    >> Share

    January 2024
  39. ARAUJO MB, Nogueira GN, Silveira PLSD, de Souza Junior SA, et al
    Insights and improvements: A critical analysis of methodological limitations in the investigation of smoking and valproic acid in treatment-resistant schizophrenia.
    Acta Psychiatr Scand. 2024 Jan 23. doi: 10.1111/acps.13659.
    >> Share

  40. DREVINSKAITE M, Kaceniene A, Patasius A, Stukas R, et al
    Cancer mortality and morbidity among patients with schizophrenia: A hospital-based cohort study, 1992-2020.
    Acta Psychiatr Scand. 2024 Jan 3. doi: 10.1111/acps.13651.
    >> Share

    December 2023
  41. EDVARDSEN E, Moszkowicz M, Olsen AL, Heinrichsen M, et al
    Clinical and sociodemographic features in offspring aged 0-3 years of mothers with schizophrenia spectrum disorders. A descriptive cross-sectional study.
    Acta Psychiatr Scand. 2023 Dec 10. doi: 10.1111/acps.13641.
    >> Share

  42. OLOYEDE E, Dima A, Taylor D, Cheung H, et al
    Clozapine augmentation with long-acting antipsychotic injections: A case series and systematic review.
    Acta Psychiatr Scand. 2023;148:538-552.
    >> Share

    November 2023
  43. JOHN AP, Mya T, Haywood D
    Cognitive deficits among people with schizophrenia and prediabetes or diabetes.
    Acta Psychiatr Scand. 2023 Nov 10. doi: 10.1111/acps.13627.
    >> Share

    September 2023
  44. TSUKAHARA M, So R, Yoshimura Y, Yamashita R, et al
    Effect of smoking habits and concomitant valproic acid use on relapse in patients with treatment-resistant schizophrenia receiving clozapine: A 1-year retrospective cohort study.
    Acta Psychiatr Scand. 2023 Sep 8. doi: 10.1111/acps.13612.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016